Imagine knowing that you have a disease that could potentially lead to cancer, and having to live in a state of constant uncertainty about whether or not a tumor would develop. For people with Human Papillomavirus (HPV), the most common sexually transmitted disease in the United States, this is a reality. HPV is a serious disease that can lead to cervical cancer (along with other types). Although there is now a vaccines for the disease, there is no known cure for those already afflicted. Life science researchers at The University of Texas Health Science Center (UTHealth) in Houston have recently discovered that an extract from shiitake mushrooms could potentially lead to a cure for HPV.Read More
Science Market Update
Exxon Mobil, the most traded international oil and gas company in the world, donates millions of dollars annually to community organizations that work with the sciences, health and education. The company, which has headquarters in both Irving and Houston, Texas, has a long history of helping out local Texas organizations. Keeping with its commitment to working in Texas, Exxon Mobil recently announced that it will donate $18 million to three research institutions located within the Texas Medical Center in Houston.Read More
As the largest state in the continental U.S. and the second most populous state of all 50, it is no wonder that the Lone Star State is known for being BIG. Amongst the big things in Texas are three world-class research institutions: University of Texas Austin, Texas A&M University in College Station, and Texas Medical Center in Houston.Read More
There are thousands of genes in the human genome that all have different purposes. At least 3,000 of these genes are known to express proteins that can be altered by different medications, however, the FDA has only approved drugs that target around 10 percent of these genes. That means that there are still thousands of genes that have not been thoroughly studied that, with the help of the right medication, could be targeted to help improve human health. The National Institutes of Health Common Fund has awarded 8 U.S. institutions $5.8 million for a new collaborative three-year program called Illuminating the Druggable Genome (IDG) that will study different genes and their potential to be modified by different medicines.Read More
Tags: CA, Mount Sinai School of Medicine, University of California San Francisco, Texas Medical Center, New York, Southwest, 2015, MSSM, tmc, San Francisco, SFVS, BioResearch Product Faire Event, Houston, NY, TX, UC San Francisco, Biotechnology Vendor Showcase Event, North East
After undergoing cancer treatments such as chemotherapy, many people experience a lapse in memory, known as chemo brain. Along with memory problems, chemo brain can also include having trouble concentrating, taking more time to finish simple tasks, and having trouble multi-tasking. The cause of chemo brain is currently unknown, but researchers at the University of Texas Health Science Center in Houston (UTHealth) have recently discovered a possible cause of chemo brain. (Image on right courtesy of Wikimedia).Read More
2014 started off with a bang in terms of interest in lab products at Texas A&M and the Texas Medical Center BioResearch Product Faire™ Sales Events last week, with 60 lab suppliers presenting their 2014 offerings to the over 600 participating researchers seeking new products, networking, and fact finding.
If you are a researcher interested in learning about the latest life science solutions available on the laboratory supply market, Biotechnology Calendar, Inc. invites you to meet other researchers and lab supply sales reps at our Houston BioResearch Product Faire™ Event on January 30th, 2014. This event is the perfect opportunity to network with colleagues and find the right life science solutions to your problems in the lab.
The traditional glaucoma treatment market for Americans suffering from glaucoma has been limited in the past, but Texas Medical Center doctors now have access to a new, minimally invasive treatment available only at the Houston Methodist Hospital. Glaucoma causes increased fluid pressure on the eye and cause blindness if it goes untreated. Traditional treatments include eye drops and surgery, which entails cutting a small hole in the eye to drain the fluid. (Texas Medical Center)
Tags: 2014, 2013, sell lab equipment, Texas Medical Center, Texas, Southwest, glaucoma treatment, tmc, BioResearch Product Faire Event, Houston, TX, life science marketing events, life science marketing opportunities
The southernmost tip of the great state of Texas is known as the Rio Grande Valley (see map below), and University of Texas Chancellor Francisco G. Cigarroa is campaigning hard for the establishment of a South Texas School of Medicine, to be part of a new regional University of Texas research campus. UT already has two smaller campuses in the Rio Grande Valley, in Edinburg and Brownsville; mid-way between those two border cities is Harlingen, which is currently home to a Regional Academic Health Center that, under the Cigarroa plan, would become a full-fledged medical school. The new UT university campus would incorporate both the Brownsville and Edinburg college campuses, but with greater resources available to strengthen its research capacity. UT System Board of Regents voted to approve both plans last month. The next step is to convince the state legislature to give its support.
Tags: 2014, 2013, University of Texas, Texas Medical Center, Texas, Southwest, UTAust, UT Health Science Center San Antonio, UTxSA, University of Texas Health Science Center, Austin, College Station, TAMU, tmc, BioResearch Product Faire Event, San Antonio, Houston, Front Line event, TX, Texas A&M, new facilities, Southwest Region
Storms both meteorological and political have dominated the front page news in the past month, but the upset that has rocked Texas' Cancer Prevention & Research Institute (CPRIT) since the spring continues to make headlines in the science press. The journal Nature has published regular editorials since the flap began, intensifying in late October with the exodus of chief scientific officer and Nobel winner Alfred Gilman (right) and nearly 30 other scientists from the state cancer funding agency's review board. Here is our recap of the story, the issues at stake, and a look at where CPRIT is positioned to go from here.